Exemplos de uso de Distribution modalities em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
The final content,format and distribution modalities of both documents should be agreed with the national competent authority in each Member State.
In each Member State, the Marketing Authorisation Holder shall agree the format and content of the educational programme,including communication media, distribution modalities, and any other aspects of the programme with the National Competent Authority.
The MAH should agree the final content,format and distribution modalities of the Prescriber checklist and the Administration and monitoring guide with the National Competent Authority in each Member State and ensure that the materials contain the key elements as described below.
Prior to launch of Jinarc in each Member State the Marketing Authorisation Holder must agree the content and format of the educational programme,including communication media and distribution modalities with each National Competent Authority.
The Russians agreed to discuss the draft first in the Security Council andthen discuss the organization and distribution modalities, the question of security forces in Kosovo. Giving in first to something and then discussing another important issue is not good tactics. You give in and when you start discussing then they ask for more.
Prior to launch of Scenesse in each Member State, the Marketing Authorisation Holder(MAH) must agree the content and format of the educational package,including communication media, distribution modalities, and any other aspects, with the National Competent Authority.
Prior to launch of KEYTRUDA in each Member State the MAH must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Toujeo 300 units/ml in each Member State the Marketing Authorisation Holder(MAH) must agree the content and format of the educational programme,including communication media, distribution modalities, and any other aspects, with the National Competent Authority.
Prior to launch of OPDIVO in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of EXJADE in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
The Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme and a follow-up pregnancy questionnaire,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
The Marketing Authorisation Holder(MAH) must agree on the content and format of the educational materials for use of VPRIV in home infusion,including communication media, distribution modalities and any other aspects of the programme, with the National Competent Authority.
Prior to the use of Rienso in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Obizur in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Nivolumab BMS in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Kanuma in each Member State the Marketing Authorisation Holder(MAH) must agree about the content andformat of the educational material including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Zalviso in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Cerdelga in each Member State the Marketing Authorisation Holder(MAH) must agree the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Sialanar in each Member State, the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational materials,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Intuniv in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of BLINCYTO in each Member State, the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to the use of Myclausen in each Member State(MS) the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational programme and a follow-up pregnancy questionnaire,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Portrazza(necitumumab) in each Member State the MAH must agree about the content and format of the educational material,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Lixiana in each Member State, the Marketing Authorisation Holder(MAH) must agree the content and format of the educational programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of IMLYGIC in each Member State the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational and controlled distribution programme,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
Prior to launch of Strimvelis in each Member State, the Marketing Authorisation Holder(MAH) must agree about the content and format of the educational materials for parents/carers and health professionals, restricted prescription details and controlled access/product consent form,including communication media, distribution modalities, and any other aspects of the programme, with the National Competent Authority.
The target audience and the modalities for distribution all of these materials are to be agreed at Member State level.
The target audience and the modalities for distribution of all of these materials are to be agreed at Member State Level.